Now is Our Opportunity to Revolutionise Cancer Clinical Trials

被引：0

作者：

Bliss, J. ^{[1
]}

Brown, J. ^{[2
]}

Chalmers, A. ^{[3
]}

Lemoine, N. ^{[4
]}

Murphy, G. ^{[5
]}

Wydenbach, K. ^{[6
]}

Frame, I. ^{[5
]}

机构：

[1] Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England

[2] Leeds Inst Clin Trials Res, Clin Trials Res Unit, Leeds LS29JT, England

[3] Univ Glasgow, Univ Ave, G12, Glasgow City, Scotland

[4] NIHR Clin Res Network Coordinating Ctr, Minerva House Montague Cl, London SE1 9DF, England

[5] Natl Canc Res Inst NCRI, Redman Pl, London E20 1JQ, England

[6] Med & Healthcare Prod Regulatory Agcy South Colonn, Canary Wharf, London E14 4PU, England

来源：

CLINICAL ONCOLOGY | 2023年 / 35卷 / 03期

关键词：

D O I：

10.1016/j.clon.2022.10.018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：139 / 142

页数：4

共 9 条

[1] Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial [J].

Adams, Richard A. ;

Fisher, David J. ;

Graham, Janet ;

Seligmann, Jenny F. ;

Seymour, Matthew ;

Kaplan, Richard ;

Yates, Emma ;

Parmar, Mahesh ;

Richman, Susan D. ;

Quirke, Philip ;

Butler, Rachel ;

Brown, Ewan ;

Collinson, Fiona ;

Falk, Stephen ;

Wasan, Harpreet ;

Shiu, Kai-Keen ;

Middleton, Gary ;

Samuel, Leslie ;

Wilson, Richard H. ;

Brown, Louise C. ;

Maughan, Timothy S. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (33) :3693-+

[2] Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis [J].

Crocker, Joanna C. ;

Ricci-Cabello, Ignacio ;

Parker, Adwoa ;

Hirst, Jennifer A. ;

Chant, Alan ;

Petit-Zeman, Sophie ;

Evans, David ;

Rees, Sian .

BMJ-BRITISH MEDICAL JOURNAL, 2018, 363

[3] Evolution of the Randomized Clinical Trial in the Era of Precision Oncology [J].

Del Paggio, Joseph C. ;

Berry, John S. ;

Hopman, Wilma M. ;

Eisenhauer, Elizabeth A. ;

Prasad, Vinay ;

Gyawali, Bishal ;

Booth, Christopher M. .

JAMA ONCOLOGY, 2021, 7 (05) :728-734

[4] Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI plus ): Interim analysis of an open-label randomised controlled trial [J].

Jackson, Graham H. ;

Pawlyn, Charlotte ;

Cairns, David A. ;

de Tute, Ruth M. ;

Hockaday, Anna ;

Collett, Corinne ;

Jones, John R. ;

Kishore, Bhuvan ;

Garg, Mamta ;

Williams, Cathy D. ;

Karunanithi, Kamaraj ;

Lindsay, Jindriska ;

Rocci, Alberto ;

Snowden, John A. ;

Jenner, Matthew W. ;

Cook, Gordon ;

Russell, Nigel H. ;

Drayson, Mark T. ;

Gregory, Walter M. ;

Kaiser, Martin F. ;

Owen, Roger G. ;

Davies, Faith E. ;

Morgan, Gareth J. .

PLOS MEDICINE, 2021, 18 (01)

[5] Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy [J].

James, N. D. ;

de Bono, J. S. ;

Spears, M. R. ;

Clarke, N. W. ;

Mason, M. D. ;

Dearnaley, D. P. ;

Ritchie, A. W. S. ;

Amos, C. L. ;

Gilson, C. ;

Jones, R. J. ;

Matheson, D. ;

Miliman, R. ;

Attard, G. ;

Chowdhury, S. ;

Cross, W. R. ;

Gillessen, S. ;

Parker, C. C. ;

Russell, J. M. ;

Berthold, D. R. ;

Brawley, C. ;

Adab, F. ;

Aung, S. ;

Birtle, A. J. ;

Bowen, J. ;

Brock, S. ;

Chakraborti, P. ;

Ferguson, C. ;

Gale, J. ;

Gray, E. ;

Hingorani, M. ;

Hoskin, P. J. ;

Lester, J. F. ;

Malik, Z. I. ;

McKinna, F. ;

McPhail, N. ;

Money-Kyrle, J. ;

O'Sullivan, J. ;

Parikh, O. ;

Protheroe, A. ;

Robinson, A. ;

Srihari, N. N. ;

Thomas, C. ;

Wagstaff, J. ;

Wylie, J. ;

Zarkar, A. ;

Parmar, M. K. B. ;

Sydes, M. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04) :338-351

[6]

National Institute for Health Research, 2020, IMPR INCL UND SERV G

[7]

Turner NC, 2020, LANCET ONCOL, V21, P1296, DOI [10.1016/S1470-2045(20)30444-7, 10.11016/S1470-2045(20)30444-7]

[8]

UK Government, 2022, UK GOV SETS OUT BOLD

[9]

University of Oxford, 2022, RECOVERY

← 1 →